Anirudh Kumar

Our mission is to develop first-in-class agents that will dramatically improve the lives of people living with Parkinson’s and Alzheimer’s disease

Lophora is a clinical-stage CNS drug discovery company developing novel, next-generation, neuroactive medicines to treat neurological and psychiatric disorders, such as depressive, anxiety, eating, and mood disorders, PTSD, and substance use disorders. www.lophora.com Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate LPH-5 through funding granted by the BII (Novo Nordisk Foundation), public funds and experienced biotech investors. Lophora will initiate first-in-human trials by 2024. Efficacy of LPH-5 has been extensively characterized in vivo and has successfully completed GLP-Tox with expected CTA submission by Q2 2024.

Our mission is to develop first-in-class agents that will dramatically improve the lives of people living with Parkinson’s and Alzheimer’s disease

Sana is a digital health company driven by 25 years of research. The innovative audiovisual technology allows you to accelerate your physical recovery and improve your mental well-being, offering a more restful state of mind. The Sana device is not currently approved by the FDA for any medical condition and should be used for the purposes of rest and recovery only, until such time as appropriate clinical evidence is approved through FDA processes.

Filament Health believes that standardized, naturally-derived psychedelic medicines can improve the lives of millions of people suffering from treatable conditions. Our mission is to see them in the hands of everyone who needs them, as soon as possible. (OTCQB:FLHLF)(FSE:7QS)

The World Government Summit is a global platform dedicated to shaping the future. It sets the agenda for leaders and policymakers to debate how the next generation of governments can harness innovation and technology to solve the challenges facing humanity today and in the future.